News

Pulmonology Advisor52m
FDA Greenlights Oral Therapy for NSCLC With EGFR Exon20 Insertion Mutations
The FDA has approved Zegfrovy (sunvozertinib) for locally advanced or metastatic NSCLC with EGFR exon 20 insertion mutations.
CURE23h
FDA OKs New Test to Match Lung Cancer Patients With Targeted Therapies
The U.S. FDA has approved a new test for patients with lung cancer to match the correct individuals with a targeted treatment ...